REFERENCES
- Andrew S. E., Goldberg Y. P., Kremer B., Suitieri F., Teilmann J., Zeisler J., Telenius H., Adam S., Almquist E., Anvret M., Lucotte G., Stoessl A. J., Campanella G., Hayden M. R. Huntington disease without CAG expansion: Phenocopies or errors in assignment?. American Journal of Human Genetics 1994; 54: 852–863
- Conrad C., Vianna C., Freeman M., Davies P. A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. Proceedings of the National Academy of Sciences U S A 2002; 99: 7751–7756
- Conrad C., Vianna C., Schultz C., Thal D. R., Ghebremedhin E., Lenz J., Braak H., Davies P. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease. Journal of Neurochemistry 2004; 89: 179–188
- Curtis A. R. J., Fey C., Morris C. M., Bindoff L. A., Ince P. G., Chinnery P. F., Coulthard A., Jackson M. J., Jackson A. P., McHale D. P., Hay D., Barker W. A., Markham A. F., Bates D., Curtis A., Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nature Genetics 2001; 28: 350–354
- De Silva R, Hope A., Pittman A., Weale M. E., Morris H. R., Wood N. W., Lees A. J. Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy. Neurology 2003; 61: 407–409
- Ezquerra M., Campdelacreu J., Munoz E., Oliva R., Tolosa E. Sequence analysis of tau 3’untranslated region and saitohin gene in sporadic progressive supranuclear palsy. Journal of Neurology Neurosurgery and Psychiatry 2004; 75: 155–157
- Fujii T., Fujii J., Taniguchi N. Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. European Journal of Biochemistry 2001; 268: 218–225
- Gao L., Tse S. W., Conrad C., Andreadis A. Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6. The Journal of Biological Chemistry 2005; 280: 39268–39272
- Harper P. S. Huntington's disease. W. B. Saunders, London 1991
- Holmes S. E., O’Hearn E., Rosenblatt A., Callahan C., Hwang H. S., Ingersoll-Ashworth R. G., Fleisher A., Stevanin G., Brice A., Potter N. T., Ross C. A., Margolis R. L. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nature Genetics 2001; 29: 377–378
- Holzer M., Craxton M., Jakes R., Arendt T., Goedert M. Tau gene (MAPT) sequence variation among primates. Gene 2004; 341: 313–322
- Keckarevic M., Savic D., Svetel M., Kostic V., Vukosavic S., Romac S. Yugoslav HD phenocopies analyzed on the presence of mutations in PrP, ferritin, and Jp-3 genes. International Journal of Neuroscience 2005; 115: 299–301
- Levecque C., Elbaz A., Clavel J., Vidal J. S., Amouyel P., Alperovitch A., Tzourio C., Chartier-Harlin M. C. Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 2004; 75: 478–480
- Moore R. C., Xiang F., Monaghan J., Han D., Zhang Z., Edstrom L., Anvret M., Prusiner S. B. Huntington disease phenocopy is a familial prion disease. American Journal of Human Genetics 2001; 69: 1385–1388
- The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971–983
- Verpillat P., Ricard S., Hannequin D., Dobois B., Bou J., Camuzat A., Pradier L., Frebourg T., Brice A., Clerget-Darpoux F., Deleuze J. F., Campion D. Is the Saitohin gene involved in neurodegenerative diseases?. Annals of Neurology 2002; 52: 829–832
- Wang X., Phelan S. A., Forsman-Semb K., Taylor E. F., Petros C., Brown A., Lerner C. P., Paigen B. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. The Journal of Biological Chemistry 2003; 278: 25179–25190